MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Recent advances in the discovery of small molecule c Met Kinase inhibitors ScienceDirect Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted c MET transactivation. The potency and endurance of c MET triggered Download Scientific Diagram HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease